Á lódáil...
Antithrombin III prevents progression of chronic kidney disease following experimental ischaemic‐reperfusion injury
Acute kidney disease (AKI) leads to increased risk of progression to chronic kidney disease (CKD). Antithrombin III (ATIII) is a potent anticoagulant with anti‐inflammatory properties, and we previously reported that insufficiencies of ATIII exacerbated renal ischaemia‐reperfusion injury (IRI) in ra...
Na minha lista:
| Foilsithe in: | J Cell Mol Med |
|---|---|
| Main Authors: | , , , , , , , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
John Wiley and Sons Inc.
2017
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5706518/ https://ncbi.nlm.nih.gov/pubmed/28767184 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.13261 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|